These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1706295)

  • 1. Interaction of thrombin with endothelial cells in the presence of fibrinogen and alpha 2-macroglobulin.
    Léránt I; Kovács T; Papp B; Mandl J; Lambin P; Machovich R
    Haematologia (Budap); 1990; 23(3):161-9. PubMed ID: 1706295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin].
    Fischer AM; Bros A; Rafowicz S; Josso F
    C R Seances Acad Sci D; 1979 Mar; 288(10):887-9. PubMed ID: 89015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody (SZ-53) against thrombomodulin inhibits thrombin-mediated release of t-PA and PGI2 from endothelial cells.
    Zhou Q; Zhao Y; Li P; Bai X; Ruan C
    Nouv Rev Fr Hematol (1978); 1991; 33(4):281-6. PubMed ID: 1664094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
    Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
    Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S; Freed TA; Gonias SL
    Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
    Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
    Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin and thrombin localization on the vascular endothelium; their internalization and transcytosis by plasmalemmal vesicles.
    Horvat R; Palade GE
    Eur J Cell Biol; 1993 Aug; 61(2):299-313. PubMed ID: 8223719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin and haemostasis: regulation of the biological functions of thrombin. (Facts and perspectives).
    Machovich R; Horváth I
    Haematologia (Budap); 1981 Dec; 14(4):339-59. PubMed ID: 6178655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton.
    van de Stolpe A; Jacobs N; Hage WJ; Tertoolen L; van Kooyk Y; Nováková IR; de Witte T
    Thromb Haemost; 1996 Jan; 75(1):182-9. PubMed ID: 8713799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
    Séguin C; Abid MR; Spokes KC; Aird WC
    Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetics of thrombin-thrombomodulin interaction.
    Vindigni A; White CE; Komives EA; Di Cera E
    Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells.
    Maruyama Y; Maruyama I; Soejima Y
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1262-9. PubMed ID: 8147869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation].
    Luk'ianenko EF; Kireeva EG; Strukova SM
    Biull Eksp Biol Med; 1988 Nov; 106(11):517-9. PubMed ID: 2848597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells.
    Yan W; Tiruppathi C; Qiao R; Lum H; Malik AB
    J Cell Physiol; 1996 Mar; 166(3):561-7. PubMed ID: 8600159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.